- Q2 2024 Regenxbio Inc Earnings Call TranscriptAug 01, 2024$13.31 (-6.60%)Earnings
- Q1 2024 Regenxbio Inc Earnings Call TranscriptMay 08, 2024$16.67 (-1.71%)Earnings
- Regenxbio Inc To Discuss Interim Clinical Data TranscriptMar 05, 2024
- Q4 2023 Regenxbio Inc Earnings Call TranscriptFeb 27, 2024$20.02 (+9.16%)Earnings
- Regenxbio Inc Interim Data Update TranscriptJan 16, 2024
- Regenxbio Inc at Stifel Healthcare Conference TranscriptNov 14, 2023
- Q3 2023 Regenxbio Inc Earnings Call TranscriptNov 08, 2023$16.41 (-0.18%)Earnings
- Regenxbio Inc Interim Data Update TranscriptNov 06, 2023
- Regenxbio Inc at World Muscle Society 2023 Data Update TranscriptOct 03, 2023
- Regenxbio Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 Regenxbio Inc Earnings Call TranscriptAug 02, 2023$18.9 (-1.31%)Earnings
- Regenxbio Inc to Host Virtual Investor Day TranscriptJul 11, 2023
- Regenxbio Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Regenxbio Inc at Barclays Virtual Gene Editing & Therapy Summit TranscriptMay 24, 2023
- Regenxbio Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 16, 2023
- Regenxbio Inc at Bank of America Global Healthcare Conference TranscriptMay 11, 2023
- Q1 2023 Regenxbio Inc Earnings Call TranscriptMay 03, 2023$20.23 (+3.80%)Earnings
- Regenxbio Inc at Chardan Genetic Medicines & Cell Therapy Manufacturing Summit (Virtual) TranscriptApr 25, 2023
- Regenxbio Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Q4 2022 Regenxbio Inc Earnings Call TranscriptFeb 28, 2023$22.25 (+1.41%)Earnings
- Regenxbio Inc To Discuss Interim Data Update Call TranscriptFeb 11, 2023
- Regenxbio Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Regenxbio Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 08, 2022
- Regenxbio Inc at Piper Sandler Healthcare Conference TranscriptDec 01, 2022
- Q3 2022 Regenxbio Inc Earnings Call TranscriptNov 03, 2022$21.05 (-13.16%)Earnings
- Regenxbio Inc To Discuss RGX-314 For The Treatment Of Wet AMD Call TranscriptOct 03, 2022
- Regenxbio Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 14, 2022
- Q2 2022 Regenxbio Inc Earnings Call TranscriptAug 03, 2022$33.99 (+6.85%)Earnings
- Regenxbio Inc at UBS Global Healthcare Conference TranscriptMay 24, 2022
- Regenxbio Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Regenxbio Inc Earnings Call TranscriptMay 04, 2022$28.44 (+0.78%)Earnings
- Regenxbio Inc at Barclays Global Healthcare Conference TranscriptMar 17, 2022
- Q4 2021 Regenxbio Inc Earnings Call TranscriptMar 01, 2022$26.45 (+0.92%)Earnings
- Regenxbio Inc at Barclays Gene Editing & Gene Therapy Summit (Virtual) TranscriptNov 15, 2021
- Q3 2021 Regenxbio Inc Earnings Call TranscriptNov 02, 2021$36.59 (+1.19%)Earnings
- Regenxbio Inc at Chardan Genetic Medicines Conference (Virtual) TranscriptOct 05, 2021
- Regenxbio Inc KOL Conference Call to Discuss RGX-314 Data Presentations TranscriptOct 01, 2021
- Regenxbio Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- Regenxbio Inc Call to Discuss Eye Care Collaboration with Abbvie Inc TranscriptSep 13, 2021
- Q2 2021 Regenxbio Inc Earnings Call TranscriptAug 09, 2021$32.5 (+3.80%)Earnings
- Regenxbio Inc at Bank of America NAPA Healthcare Conference (Virtual) TranscriptJun 16, 2021
- Regenxbio Inc at UBS Global Healthcare Virtual Conference TranscriptMay 25, 2021
- Regenxbio Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 12, 2021
- Q1 2021 Regenxbio Inc Earnings Call TranscriptMay 05, 2021$32.46 (-1.87%)Earnings
- Regenxbio Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 09, 2021
- Q4 2020 Regenxbio Inc Earnings Call TranscriptMar 01, 2021$42.51 (+3.91%)Earnings
- Regenxbio Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Regenxbio Inc at Barclays Virtual Gene Editing & Gene Therapy Summit TranscriptNov 16, 2020
- Regenxbio Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 12, 2020
- Q3 2020 Regenxbio Inc Earnings Call TranscriptNov 04, 2020$31.06 (+8.26%)Earnings
- Regenxbio Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2020
- Q2 2020 Regenxbio Inc Earnings Call TranscriptAug 06, 2020$34.3 (+0.32%)Earnings
- Regenxbio Inc RGX-314 Update Call TranscriptAug 04, 2020
- Q1 2020 Regenxbio Inc Earnings Call TranscriptMay 07, 2020$40.85 (-0.95%)Earnings
- Regenxbio Inc REGENXBIO RGX-314 Phase I/IIa Trial Update TranscriptApr 22, 2020
- Regenxbio Inc at Barclays Global Healthcare Conference TranscriptMar 11, 2020
- Q4 2019 Regenxbio Inc Earnings Call TranscriptFeb 26, 2020$47.5 (-0.08%)Earnings
- Q3 2019 Regenxbio Inc Earnings Call TranscriptNov 05, 2019$37.62 (+1.40%)Earnings
- Regenxbio Inc at Morgan Stanley Healthcare Conference TranscriptSep 10, 2019
- Regenxbio Inc, Uniqure NV at Citi Biotech Conference TranscriptSep 04, 2019
- Q2 2019 Regenxbio Inc Earnings Call TranscriptAug 07, 2019$40.54 (-1.36%)Earnings
- Regenxbio Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 15, 2019
- Q1 2019 Regenxbio Inc Earnings Call TranscriptMay 07, 2019$49.88 (-4.66%)Earnings
- Regenxbio Inc at Barclays Global Healthcare Conference TranscriptMar 13, 2019
- Q4 2018 Regenxbio Inc Earnings Call TranscriptFeb 27, 2019$53.24 (+0.64%)Earnings
- Regenxbio Inc Analyst and Investor Event TranscriptFeb 21, 2019
Regenxbio Inc at Barclays Global Healthcare Conference Transcript
Good afternoon, everyone. My name is Gena Wang, I'm a mid-cap biotech analyst at Barclays. It is my great pleasure to introduce our next speaker, Ken Mills from REGENXBIO.
Thanks, Gena. Good afternoon, everyone. Appreciate the opportunity that Gena and the team have afforded us to present on REGENXBIO today. Forward-looking statements and risk factors can be found in more detail in our disclosures on the SEC website.
REGENXBIO: People, plan, science and the mission. Seeking improved lives through the curative potential of gene therapy, the people at REGENXBIO and our partners are currently focused on over 30 programs in preclinical or clinical stages. Inside the company, we have 200 people in Rockville, Maryland, focused on advancing 4 clinical-stage programs. Outside through partnership, we have over 14 clinical-stage programs with some of the most advanced programs on the cusp of a punitive approval here in the first
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)